JP2022535527A5 - - Google Patents
Info
- Publication number
- JP2022535527A5 JP2022535527A5 JP2021571613A JP2021571613A JP2022535527A5 JP 2022535527 A5 JP2022535527 A5 JP 2022535527A5 JP 2021571613 A JP2021571613 A JP 2021571613A JP 2021571613 A JP2021571613 A JP 2021571613A JP 2022535527 A5 JP2022535527 A5 JP 2022535527A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- use according
- antibody
- patient
- adc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025129110A JP2025172753A (ja) | 2019-06-04 | 2025-08-01 | 自己免疫疾患を治療するための方法および組成物 |
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962857232P | 2019-06-04 | 2019-06-04 | |
| US62/857,232 | 2019-06-04 | ||
| US201962863141P | 2019-06-18 | 2019-06-18 | |
| US62/863,141 | 2019-06-18 | ||
| US201962882310P | 2019-08-02 | 2019-08-02 | |
| US62/882,310 | 2019-08-02 | ||
| US201962933279P | 2019-11-08 | 2019-11-08 | |
| US62/933,279 | 2019-11-08 | ||
| US201962944988P | 2019-12-06 | 2019-12-06 | |
| US62/944,988 | 2019-12-06 | ||
| US202062968870P | 2020-01-31 | 2020-01-31 | |
| US62/968,870 | 2020-01-31 | ||
| US202063030860P | 2020-05-27 | 2020-05-27 | |
| US63/030,860 | 2020-05-27 | ||
| PCT/US2020/036177 WO2020247670A1 (en) | 2019-06-04 | 2020-06-04 | Methods and compositions for treating autoimmune diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025129110A Division JP2025172753A (ja) | 2019-06-04 | 2025-08-01 | 自己免疫疾患を治療するための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022535527A JP2022535527A (ja) | 2022-08-09 |
| JP2022535527A5 true JP2022535527A5 (https=) | 2023-06-23 |
Family
ID=73652045
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021571613A Pending JP2022535527A (ja) | 2019-06-04 | 2020-06-04 | 自己免疫疾患を治療するための方法および組成物 |
| JP2025129110A Pending JP2025172753A (ja) | 2019-06-04 | 2025-08-01 | 自己免疫疾患を治療するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025129110A Pending JP2025172753A (ja) | 2019-06-04 | 2025-08-01 | 自己免疫疾患を治療するための方法および組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12403200B2 (https=) |
| EP (1) | EP3980066A4 (https=) |
| JP (2) | JP2022535527A (https=) |
| KR (1) | KR20220016922A (https=) |
| CN (2) | CN114173820B (https=) |
| AU (1) | AU2020289360A1 (https=) |
| BR (1) | BR112021024328A2 (https=) |
| CA (1) | CA3140180A1 (https=) |
| IL (1) | IL288563A (https=) |
| MX (1) | MX2021014729A (https=) |
| SG (1) | SG11202113331QA (https=) |
| WO (1) | WO2020247670A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020092655A1 (en) * | 2018-10-30 | 2020-05-07 | Magenta Therapeutics, Inc. | Methods for allogeneic hematopoietic stem cell transplantation |
| KR20230122618A (ko) * | 2020-12-21 | 2023-08-22 | 알로젠 테라퓨틱스 인코포레이티드 | 프로테아제 활성화 cd45-게이트 car |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003048327A2 (en) * | 2001-12-03 | 2003-06-12 | Abgenix, Inc. | Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection |
| RU2683325C2 (ru) * | 2009-02-05 | 2019-03-28 | Иммьюноджен, Инк. | Новые производные бензодиазепина |
| CN110627797A (zh) * | 2012-12-21 | 2019-12-31 | 麦迪穆有限责任公司 | 用于治疗增殖性和自身免疫疾病的非对称吡咯并苯并二氮杂卓二聚物 |
| US20170226209A1 (en) * | 2014-08-01 | 2017-08-10 | INSERM (Institut National de la Santé et de la Recherche Médicale) | An anti-cd45rc antibody for use as drug |
| EP3268047B9 (en) * | 2015-03-09 | 2024-01-10 | Heidelberg Pharma Research GmbH | Amatoxin-antibody conjugates |
| HK1256681A1 (zh) * | 2015-04-06 | 2019-10-04 | President And Fellows Of Harvard College | 用於非清髓性预处理的组合物和方法 |
| EP3222292A1 (en) * | 2016-03-03 | 2017-09-27 | Heidelberg Pharma GmbH | Amanitin conjugates |
| CN109641051A (zh) * | 2016-06-17 | 2019-04-16 | 美真达治疗公司 | 用于耗尽细胞的组合物和方法 |
| KR20240093751A (ko) * | 2016-12-21 | 2024-06-24 | 노파르티스 아게 | 조혈줄기세포를 제거하기 위한 항체 약물 접합체 |
| KR20200069364A (ko) * | 2017-10-24 | 2020-06-16 | 마젠타 테라퓨틱스 인코포레이티드 | Cd117+ 세포의 고갈을 위한 조성물 및 방법 |
-
2020
- 2020-06-04 JP JP2021571613A patent/JP2022535527A/ja active Pending
- 2020-06-04 EP EP20819317.7A patent/EP3980066A4/en active Pending
- 2020-06-04 CN CN202080055620.9A patent/CN114173820B/zh active Active
- 2020-06-04 BR BR112021024328A patent/BR112021024328A2/pt not_active IP Right Cessation
- 2020-06-04 WO PCT/US2020/036177 patent/WO2020247670A1/en not_active Ceased
- 2020-06-04 SG SG11202113331QA patent/SG11202113331QA/en unknown
- 2020-06-04 CN CN202511717645.1A patent/CN121796623A/zh active Pending
- 2020-06-04 MX MX2021014729A patent/MX2021014729A/es unknown
- 2020-06-04 CA CA3140180A patent/CA3140180A1/en active Pending
- 2020-06-04 KR KR1020217043420A patent/KR20220016922A/ko active Pending
- 2020-06-04 AU AU2020289360A patent/AU2020289360A1/en active Pending
-
2021
- 2021-11-30 IL IL288563A patent/IL288563A/en unknown
- 2021-12-03 US US17/457,583 patent/US12403200B2/en active Active
-
2025
- 2025-08-01 JP JP2025129110A patent/JP2025172753A/ja active Pending
- 2025-08-27 US US19/312,214 patent/US20260069706A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019522680A5 (https=) | ||
| CN113710277B (zh) | 一种负载双毒素的抗体药物偶联物及其应用 | |
| JP7337833B2 (ja) | 縮合二環式Ｃ５ａＲアンタゴニストのプロドラッグ | |
| AU2019205542B2 (en) | Steroids and antibody-conjugates thereof | |
| JP7062647B2 (ja) | Ｃｄ１１７＋細胞を枯渇させるための組成物及び方法 | |
| ES2274865T3 (es) | Anticuerpos recombinantes para la interleuquina-1 beta humana. | |
| US20220175951A1 (en) | Anti-CD45 Antibody Drug Conjugates and Uses Thereof | |
| JP2024096703A (ja) | Ｃｄ５＋細胞の枯渇のための組成物および方法 | |
| JP7730836B2 (ja) | 抗体薬物複合体の調製方法 | |
| CN100374457C (zh) | 抗il-6抗体、组合物、方法和用途 | |
| AU2020205851B2 (en) | Conjugate comprising ligand, spacer, peptide linker, and biomolecule | |
| ES2774422T3 (es) | Anticuerpos para IL-21 | |
| JP2007204497A (ja) | ジペプチジル−アミノペプチダーゼ・ｉｖ型の阻害剤 | |
| RU2010153580A (ru) | Иммуноглобулины с двумя вариабельными доменами и их применение | |
| EA031044B1 (ru) | Человеческие антитела к онкостатину м и способы их применения | |
| BR112019012483A2 (pt) | conjugados de fármaco de anticorpo para ablar células-tronco hematopoiéticas | |
| JP2022535527A5 (https=) | ||
| WO1997019111A9 (es) | Anticuerpos monoclonales anti-cd6 y sus utilizaciones | |
| ES2875762T3 (es) | Uso terapéutico de ligando específico en enfermedades asociadas a MSRV | |
| AU2023260131A1 (en) | Antibody-drug conjugate, pharmaceutical composition thereof and use thereof | |
| ES3054393T3 (en) | Thienopyrrole compounds | |
| JP2022529726A5 (https=) | ||
| WO2020219775A1 (en) | Anti-cd117 antibody-drug conjugates and uses thereof | |
| EP3958899A2 (en) | Anti-cd117 antibody-drug conjugates and uses thereof | |
| BR112020011186A2 (pt) | regimes de dosagem para a mobilização de células-tronco e progenitoras hematopoiéticas |